Last updated on May 2020

Safety and Efficacy of T8 on Treating Chronic Abnormal Immune Activation in AIDS Patients


Brief description of study

  1. To evaluate the efficacy and safety of taking T8 once daily on treating chronic abnormal immune activation in AIDS patients.
  2. To explore dose-effect relationships of taking T8 once dailyon treating chronic abnormal immune activation in AIDS patients.

Clinical Study Identifier: NCT04084444

Find a site near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.